Clinical Trial: Study to Investigate the Efficacy and Safety of the Alpha‐2‐Delta Ligand PD‐217,014 in Patients With Irritable Bowel Syndrome. - Houghton, Lesley A.; Gao, Simiao; Gilbert, Steven A.; Coffin, Benoit; Simren, Magnus; Gale, Jeremy D. (Alimentary Pharmacology & Therapeutics, 2025)